Diffuse Large Cell Lymphoma
Links shared publicly online about this topic
Diffuse Large B-Cell Lymphoma with Calf Muscle Localization
hindawi.com — “Although diffuse large B-cell lymphoma (DLBCL) usually occurs in the lymph nodes, approximately 30–40% of the time it can have an extranodal site of involvement and it can arise in nearly every body site such as intestine, bone, breast, liver, skin, lung, and central nervous system. Muscle involvement of DLBCL is especially uncommon, comprising 0.5% of extranodal NHL. We report a case of a 72-year-old man with extranodal DLBCL of a unique manifestation in the calf muscle, involving predominantly” View full resource at hindawi.com
Most Recently Shared on July 9, 2011 at 11:23 pm By:
Diffuse Large B-Cell Lymphoma with Calf Muscle Localization: We report a case of a 72-year-old man with extranod... http://bit.ly/ng4HWW
Oncology Medical News about Lymphoma Lymphoma, Large B-Cell, Diffuse Prognosis
mdlinx.com — “Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab” View full resource at mdlinx.com
Most Recently Shared on June 1, 2010 at 8:16 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma tre... http://bit.ly/bkklxH #oncology
Genmab Announces Top-Line Interim Results For Ofatumumab In Diffuse Large B-Cell Lymphoma
medicalnewstoday.com — “Genmab A/S (OMX: GEN) announced today top-line interim results from an initial Phase II single arm open label studyof ofatumumab to evaluate the treatment of relapsed Diffuse Large B-CellLympho” View full resource at medicalnewstoday.com
Most Recently Shared on August 11, 2010 at 2:00 pm By:
Genmab Announces Top-Line Interim Results For Ofatumumab In Diffuse Large B-Cell Lymphoma http://mnt.to/3HdC #lymphoma #leukemia
Evolving Strategies Using Hematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Non-Hodgkin Lymphoma
onclive.com — “Diffuse large B-cell non-Hodgkin lymphoma is typically a chemotherapy-sensitive malignancy, justifying dose-intense therapy with hematopoietic stem cell transplantation for patients unlikely to achieve cure with standard-dose regimens.” View full resource at onclive.com
Most Recently Shared on August 17, 2011 at 1:11 pm By:
Evolving Strategies Using Hematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Non-Hodgkin Lymphoma http://t.co/Pt0xoCo
Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma - MPR
empr.com — “Cell Therapeutics announced that it has initiated its trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).” View full resource at empr.com
Most Recently Shared on March 21, 2011 at 3:41 pm By:
MPR News: Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma: Cell Therap... http://bit.ly/gYTSxS
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma
bloodjournal.hematologylibrary.org — “Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma” View full resource at bloodjournal.hematologylibrary.org
Most Recently Shared on January 14, 2012 at 5:37 am By:
Brandon Hayes-Lattin Doctor, Internist, Oncologist, and Physician
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma http://t.co/jAcd7q9Z
Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma - ONA
oncologynurseadvisor.com — “Cell Therapeutics announced that it has initiated its trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 21, 2011 at 3:11 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Pixantrone PIX-R Trial for Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma http://goo.gl/fb/6TUHg
Diffuse large B-cell lymphoma with lung involvemen... [Dermatol Online J. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 27, 2010 at 10:22 pm By:
Diffuse large B-cell lymphoma with lung involvement in a psoriatic arthritis patient treated with methotrexate.: W... http://bit.ly/dBBpI2
Anemia in diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) patients. - ASCO
pda.asco.org — “Anemia in diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) patients. - ASCO - The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide, and lead the fight for more effective cancer treatments, increased funding for clinical and translational research, and, ultimately, cures for the many different cancers that strike millions of people around” View full resource at pda.asco.org
Most Recently Shared on August 6, 2010 at 6:44 pm By:
ESA's in Diffuse Large B-Cell pts to avoid anemia? Anemia associated w/ lower rates of complete response. http://bit.ly/crpOno
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on September 14, 2009 at 1:04 pm By:
UK Clinical Trial for Mediastinal B-Cell Lymphoma: http://bit.ly/18gcjD
Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma
news-medical.net — “Genmab A/S announced today top-line interim results from an initial Phase II single arm open label study of ofatumumab to evaluate the treatment of relapsed Diffuse Large B-Cell Lymphoma in patients ineligible for or relapsed following a stem cell transplant.” View full resource at news-medical.net
Most Recently Shared on August 11, 2010 at 7:29 am By:
Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma: Genmab A/... http://bit.ly/aCgSOz
Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell Lymphoma
news-medical.net — “Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.” View full resource at news-medical.net
Most Recently Shared on May 17, 2011 at 3:00 pm By:
Medicare News: Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell L... http://bit.ly/kOQq2J
Rituximab + Vinorelbine, Ifosfamide, Mitoxantrone, and Prednisone: A Suitable Salvage Treatment for Patients With Relapsed Diffuse Large B-Cell Lymphoma - ONA
oncologynurseadvisor.com — “The combination of rituximab plus vinorelbine, ifosfamide, mitoxantrone, and prednisone (R-NIMP) is well tolerated, yields a high complete response rate, and allows for successful mobilization of CD34+ cells in patients with diffuse large B-cell lymphoma (DLBCL) in first relapse, results of a phase 2 study presented at the 52nd American Society of Hematology Annual Meeting and Exposition have found.” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 6, 2010 at 4:05 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Rituximab + Vinorelbine, Ifosfamide, Mitoxantrone, and Prednisone: A Suitable Salvage… http://goo.gl/fb/YCMoS
Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on September 12, 2009 at 2:50 am By:
Clinical Trial for newly diagnosed Diffuse Large B Cell #lymphoma, V-R-Chop. http://bit.ly/XoIdV
Treatment of Large Cell Lymphoma: R-CHOP and Beyond
onclive.com — “The treatment of diffuse large B-cell lymphoma continues to evolve, as researchers seek to improve upon the current standard of care.” View full resource at onclive.com
Most Recently Shared on January 31, 2012 at 10:51 pm By:
The treatment of DLBCL continues to evolve, as researchers seek to improve upon the current standard of care http://t.co/5oCn7i0W
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
OrganizedWisdom GI
Organizing gastroenterology and digestion resources shared by health experts, advocates, and organizations into WisdomCards.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
MNT Leukemia
The latest lymphoma and leukemia news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
